Biotech's 10 Biggest PR Disasters of 2012
By GMWatch,
GMWatch
| 12. 31. 2012
The 10 biggest GMO PR disasters of 2012
[For links, please refer to the original article here]
2012 was the year the lights came up on the biotech industry. Its claims, its tactics and its products all came under scrutiny and some of its biggest PR fairytales bit the dust. Here are some prime examples.
1. Fleeing Europe: The biotech bubble needs to appear to be constantly expanding but in early 2012 came the news that the GM and chemicals giant BASF was pulling its GM division out of Europe because it was facing opposition "from the majority of consumers, farmers and politicians." BASF also announced it was stopping the commercialization of its GM Amflora potato, one of only two GM crops authorized for cultivation in the European Union. The crop had been a commercial flop. The industry's only other crop grown in Europe, Monsanto's Mon810 GM maize, continued to face bans in a number of countries including France and Germany. Even GM crop trials are in decline and with BASF quitting Europe they're expected to decline still further...
Related Articles
By Antonio Regalado, MIT Technology Review | 03.20.2024
There is a new most expensive drug ever—a gene therapy that costs as much as a Brooklyn brownstone or a Miami mansion, and more than the average person will earn in a lifetime.
Lenmeldy is a gene treatment for metachromatic...
By Carl Zimmer, The New York Times | 03.10.2024
In 1889, a French doctor named Francois-Gilbert Viault climbed down from a mountain in the Andes, drew blood from his arm and inspected it under a microscope. Dr. Viault’s red blood cells, which ferry oxygen, had surged 42 percent. He...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Mariella Bodemeier Loayza Careaga, The Scientist | 03.15.2024
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Humans are never alone. Even in a room devoid of other people, they are always in the company of billions of microscopic beings...